Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755493 · ClinicalTrials.gov registry record · NA
Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control
A NA study of Sleep Deprivation, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT02755493: Completed NA study of Sleep Deprivation, sponsored by Brigham and Women's Hospital.
NCT02755493 is a NA study of Sleep Deprivation that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 22 participants, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02755493, a NA study of Sleep Deprivation, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This project proposes to both develop and test adaptive automation countermeasures for the effects of stressors such as sleep deprivation (SD) on human performance related to robotic tasks, and investigate the relationship between human trust and appropriate use of these countermeasures.
Primary Outcome
Over this 72 hour time frame there will be six assessments. Once on Day1, 4 times during the sleep deprivation on Days 2-3, and once on Day 4, the participant will perform computer simulations of "missions" with tasks. The time to complete tasks will be one of the metrics. The change in metrics related to length of time of awake will be assessed using longitudinal analysis methods.
Conditions Studied
Interventions
- BEHAVIORAL Sleep deprivation
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05-31 |
| Phase | NA |
What the finished NCT02755493 record still lists
NCT02755493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Sleep Deprivation appearing as the primary indexed condition, and to 1 intervention - of which Sleep deprivation is the first listed.
NCT02755493 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02755493 about?
NCT02755493 is a clinical study titled "Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control". This project proposes to both develop and test adaptive automation countermeasures for the effects of stressors such as sleep deprivation (SD) on human performance related to robotic tasks, and investigate the relationship between human trust and appropriate use of these countermeasures.
What is the current status of trial NCT02755493?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-04. Estimated completion is 2018-05-31.
What conditions does trial NCT02755493 study?
This clinical trial studies the following conditions: Sleep Deprivation.
What interventions are being tested in trial NCT02755493?
The interventions under investigation include: Sleep deprivation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02755493?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02755493 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Deprivation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02755493's enrollment target sits among peer trials
22 29th of 34 higher than 6 of 34 other Sleep Deprivation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Deprivation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Biomarkers of Increased Free Living Sleep Time
RECRUITING · NA
-
The Function of Biphasic Sleep in Infants
RECRUITING · NA
-
Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep
RECRUITING · NA
-
Caffeine Optimization Versus Standard Caffeine Dosage (2B-2)
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
-
Menstrual-phase-dependent Differences in Response to Sleep Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia